This session will offer an overview of the present landscape of mRNA therapeutic drugs, encompassing their growing utility in medicine. It will describe the dsRNA quantitative detection and process control challenges encountered during development, and propose solutions to overcome these challenges. Moreover, the session will shine a spotlight on Vazyme’s pioneering contributions to mRNA raw materials and process innovation, highlighting significant strides in this domain.